Navigation Links
New consensus on work-related asthma
Date:9/23/2008

In a new consensus statement, the American College of Chest Physicians offers guidance on the diagnosis and treatment of work-related asthma (WRA), a chronic respiratory condition that includes occupational asthma and work-exacerbated asthma (WEA) and affects as many as 25 percent of adults with asthma. Published as a supplement to the September issue of CHEST, the consensus statement, updated from 1995, places new emphasis on

  1. preventive measures, including better control of exposures;
  2. the need for a combination of diagnostic testing; and
  3. the importance of obtaining a full medical and occupational history in patients with suspected WRA.

The statement also places greater consideration on the diagnosis and management of WEA, which is preexisting or concurrent asthma that is worsened by work-related conditions. Developed by an expert panel of specialists in allergy, pulmonary medicine, and occupational medicine, the consensus statement provides supplemental materials, including a worker/workplace fact sheet and physician flow sheets to help physicians and other health-care providers diagnose and manage WRA. For more information related to the ACCP consensus statement on work-related asthma, visit www.chestjournal.org.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1

Related biology technology :

1. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
2. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
5. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
6. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. Drug Reduces Airway Mucus in Preclinical Asthma Model
11. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... ... the improvement of crop productivity and economics for the food, feed and biofuel ... of the agreement includes the research and development of microbiome-based seed treatments in ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Executive Director of Strategic Planning. His extensive background in consulting, development and ... experience encompasses marketing and differentiation consulting, business strategy development, new product marketing ...
(Date:7/24/2017)... BALTIMORE , July 24, 2017 Intralytix, ... equity funding from Lesaffre, a French family group. This ... both companies to develop and commercialize bacteriophage-based products, for ... of mutual interest. ... fermentation, Lesaffre designs manufactures and markets innovative solutions for ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... Fujimoto, Ph.D ., the Elihu Thomson Professor of Electrical Engineering and Computer Science ... Award winner. Presented annually, the award recognizes an individual who has made ...
Breaking Biology Technology:
(Date:6/30/2017)... , June 30, 2017 Today, ... developer and supplier of face and eye tracking ... Featured Product provider program. "Artificial ... innovative way to monitor a driver,s attentiveness levels ... from being able to detect fatigue and prevent ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):